NUFIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.754800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.881800E-01
Normal-vs-Stage2
5.788000E-01
Normal-vs-Stage3
3.808600E-01
Normal-vs-Stage4
1.687430E-01
Stage1-vs-Stage2
3.358600E-01
Stage1-vs-Stage3
7.119700E-02
Stage1-vs-Stage4
9.626600E-01
Stage2-vs-Stage3
8.796500E-02
Stage2-vs-Stage4
4.573800E-01
Stage3-vs-Stage4
5.297600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.784600E-01
Normal-vs-AfricanAmerican
4.606800E-01
Normal-vs-Asian
7.826600E-01
Caucasian-vs-AfricanAmerican
4.732200E-01
Caucasian-vs-Asian
6.487600E-01
AfricanAmerican-vs-Asian
4.517200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.549400E-01
Normal-vs-Female
5.950800E-01
Male-vs-Female
9.253600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.408430E-01
Normal-vs-Age(41-60Yrs)
4.086400E-01
Normal-vs-Age(61-80Yrs)
7.030200E-01
Normal-vs-Age(81-100Yrs)
3.465600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.656100E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.04009999999122E-06
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.694000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.918000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.624400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.147830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.389400E-01
Normal-vs-Daily Drinker
8.736400E-01
Normal-vs-Weekly Drinker
4.596600E-01
Normal-vs-Occasional Drinker
2.551600E-01
Normal-vs-Social Drinker
4.436600E-01
Non Drinker-vs-Daily Drinker
8.739800E-01
Non Drinker-vs-Weekly Drinker
3.513800E-01
Non Drinker-vs-Occasional Drinker
1.834980E-01
Non Drinker-vs-Social Drinker
3.687800E-01
Daily Drinker-vs-Weekly Drinker
2.553600E-01
Daily Drinker-vs-Occasional Drinker
1.330760E-01
Daily Drinker-vs-Social Drinker
2.627400E-01
Weekly Drinker-vs-Occasional Drinker
9.425000E-01
Weekly Drinker-vs-Social Drinker
9.387400E-01
Occasional Drinker-vs-Social Drinker
8.598600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.286800E-01
Normal-vs-Grade 2
6.362200E-01
Normal-vs-Grade 3
2.143600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.491600E-01
Grade 1-vs-Grade 3
6.062800E-01
Grade 1-vs-Grade 4
3.286800E-01
Grade 2-vs-Grade 3
8.629000E-01
Grade 2-vs-Grade 4
6.362200E-01
Grade 3-vs-Grade 4
2.143600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.530800E-01
Normal-vs-NonDiabetic
5.480400E-01
Diabetic-vs-NonDiabetic
5.416800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.198600E-01
Normal-vs-NoPancreatitis
5.723200E-01
Pancreatitis-vs-NoPancreatitis
6.414400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.594600E-01
Normal-vs-N1
5.666200E-01
N0-vs-N1
9.506800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.787200E-01
Normal-vs-TP53-NonMutant
5.323000E-01
TP53-Mutant-vs-TP53-NonMutant
1.011980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
